BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Sigma-aldrich Corp.

Headquarters: St. Louis, MO, United States
Website: N/A
Year Founded: 1735
Status: Acquired

BioCentury | Aug 29, 2020
Deals

Data Bytes: Cryoport deals show continued interest in cell, gene therapy manufacturing and supply chain players

Cryoport’s acquisitions of MVE Biological Solutions and CRYOPDP are the latest in a string of takeovers focused on the support network that fuels cell and gene therapies. Cell and gene
BioCentury | Feb 9, 2019
Product Development

Merck KGaA's large-scale partnering

Why Merck KGaA is partnering M7824 with GSK rather than going it alone
BioCentury | Apr 16, 2015
Company News

Management tracks

BioCentury | Mar 12, 2015
Product R&D

Extending zinc fingers

Sangamo's ZFNs permanently correct enzyme lack in lysosomal storage disorders
BioCentury | Dec 15, 2014
Company News

Broad Institute, Sigma-Aldrich deal

BioCentury | Oct 6, 2014
Finance

3Q14 Stock Wrap-Up: Going big again

Winners, losers in biotech stock tiers in 3Q14
BioCentury | Sep 29, 2014
Company News

Sigma-Aldrich, Merck KGaA deal

BioCentury | Sep 23, 2014
Top Story

Merck buying Sigma-Aldrich for $17B

BioCentury | Oct 24, 2013
Strategy

Synaptic synopsis

BioCentury | Oct 10, 2013
Translation in Brief

Translational tidbits

Items per page:
1 - 10 of 144